1Alexandrakis MG, Coulocheri SA, Bouros D, et al. Evaluation of inflammatory cytokines in malignant and benign pleural effusions. Oncol Rep, 2000, 7: 1327-1332.
2Anderson IC, Mari SE, Broderick RJ, et al. The angiogenic factor interleukin 8 is induced in non-small cell lung cancer/pulmonary fibroblast cocuhures. Cancer Res, 2000,15,60: 269-272.
4Shimokata K, Saka H, Murate T, et al. Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy. Chest, 1991, 99:1103-1107.
5Smith DR, Polverini PJ, Kunkel SL, et al. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med, 1994, 179: 1409- 1415.
1Sun Y,Tokushige K,Isono E,et al.Elevated serum interleukin-6 levels in patients with acute hepatitis[J].J Clin Immuno,1992,12(3):197-200.
2Machbaur D M.Serum levels of interleukin 6 in multiple myeloma and other hematological disorder,correlation with disease activity and other prognostic parameter[J].Ann Hematol,1991,62(2-3):54-57.
3Ito R,Kitadai R,Kyo E,et al.Interleukin lalpha acts as an autocrine growth stimulator for human gastric carcinoma cells[J].Cancer Res,1993,53(17):4102-4106.
4Niwa T,Nivazaki T,Sotom B,et al.Interleukin-8 and biocompatibility of dialysis membrance[J].Am J Nephral,1995,15(2):181.
5Dinarello D,Shibuya K,Mui A,et al.IGIF does not drive TH1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NF kappaB[J].Immunity,1997,7(4):571.
6Hashimoto W,Osaki T,Okamura H,et al.Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fasligan and perforin-induced tumor apoptosis respectively[J].Immunol,1999,163(2):583-589.
7Sugawara I,Yamada H,Kaneko H,et al.Role of interleukin-18(IL-18) in mycobacterial infection in IL-18-gene-disrupted mice[J].Infect Immun,1999,67(5):2585-2589.
9Cao R,Farnebo J,Kurimoto M,et al.Interleukin-18 acts as an angiogenesis and tumor suppressor[J].FASEB J,1999,13(15):2195-2202.
10Morel J C,Park C C,Woods J M,et al.A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol(PI) 3-kinase-dependent signal transduction pathways[J].J Biol Chem,2001,276(40):37069-37075.
2KnUpfer H, Preiss R. Serum interleukin-6 levels in colorectal cancer patients-a summary of published results. Int J Colorectal Dis,2010,25: 135-140.
3Rotondo R, Barisione G, Mastracci L, et al. IL-8 induces exocytosis of arginase 1 by neutrophil polymorphanuclears in nonsmall cell lung cancer. Int J Cancer,2009,125:887-893.
4Waugh D J, Wilson C, Seaton A, et al. Muhi-faceted roles for CXC-chemokines in prostate cancer progression. Front Biosci ,2008,13:4595-4604.
5Abdel-Hamid MF,Aly DG,Saad NE ,et al. Serum levels of interleukin-8, tumor necrosis factor-or and ,interferon in Egyptian psoriatic patients and correlation with disease severity. J Dermatol,2010,20 : 1346-8138.
6Hua YN, Xue J, Sun F, et al. Aspirin Inhibits MMP-2 and MMP-9 Expressions and Activities through Upregulation of PPAR alpha/gamma and TIMP Gene Expressions in ox-LDL-Stimulated Macrophages Derived fromHuman Monocytes. Harmacology,2009,1 : 18-25.
7Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin,2014, 64( 1 ) : 9-29.
8Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin, 2013, 63(1) : 11-30.
9Toh C K. The changing epidemiology of lung cancer. Methods Mol Bio1,2009,472 : 397-411.
10Luca M, Husang S, Gersberward J E, et al. Expression of interleukin-8 by human melanoma cell up-regulates MMP-2 activity and increase tumor growth and metastasis. Am J Patho, 1997,151 (4) :1105-1113.
